• Karan Vanni
• Jeena Gupta

-The diagnosis and detection of cancer at earlier stages is very important for the management of cancer. The presently available diagnostic blood tests are generally based on detecting the markers associated with tumors like for gastrointestinal cancer CA19-9 the cancer antigen, carcino-embryonic antigen (CEA), for breast cancer CA15-3 and for ovarian cancer CA125. However, these markers lacks specificity and sensitivity which prevents their use in the screening of cancer. Therefore new improved diagnostic techniques are required for the detection of cancer. The present review deals with modification of ELISA (Enzyme linked immunosorbant assay) in the detection of cancer.

-

"ELISA IN DETECTION OF CANCER", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.7, Issue 6, page no.1263-1266, January 2019, Available :http://www.jetir.org/papers/JETIRDY06205.pdf

"ELISA IN DETECTION OF CANCER", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.7, Issue 6, page no. pp1263-1266, January 2019, Available at : http://www.jetir.org/papers/JETIRDY06205.pdf